fluorouracil has been researched along with Corneal Diseases in 52 studies
Fluorouracil: A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the THYMIDYLATE SYNTHETASE conversion of deoxyuridylic acid to thymidylic acid.
5-fluorouracil : A nucleobase analogue that is uracil in which the hydrogen at position 5 is replaced by fluorine. It is an antineoplastic agent which acts as an antimetabolite - following conversion to the active deoxynucleotide, it inhibits DNA synthesis (by blocking the conversion of deoxyuridylic acid to thymidylic acid by the cellular enzyme thymidylate synthetase) and so slows tumour growth.
Corneal Diseases: Diseases of the cornea.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In this prospective study, 76 patients with primary pterygium (76 eyes) were categorized into two groups: the control group with 31 patients who did not receive cyclosporine treatment, and the cyclosporine group with 45 patients who received topical cyclosporine A (0." | 9.30 | Topical cyclosporine A 0.05% before and after surgery to prevent pterygium recurrence. ( Meneghim, RLFS; Natsuaki, KL; Oliveira, AC; Padovani, CR; Satto, LH; Schellini, SA; Viveiros, MMH, 2019) |
| "In a randomized clinical trial, the authors compared the use of postoperative subconjunctival injections of 5-fluorouracil (5-FU) in 19 eyes with a single intraoperative application of subconjunctival mitomycin (MMC) at the filtering site in 20 eyes at high risk for failure of glaucoma filtering surgery." | 9.07 | Intraoperative mitomycin versus postoperative 5-fluorouracil in high-risk glaucoma filtering surgery. ( Beeson, CC; Bergstrom, TJ; Falck, FY; Higginbotham, EJ; Klein, TB; Lichter, PR; Musch, DC; Skuta, GL, 1992) |
| "A 26-year-old, wild caught, male Malayan tapir at the Miami Metrozoo with bilateral corneal papillomas was serially immobilized and given subconjunctival injections of fluorouracil." | 7.71 | Fluorouracil as a treatment for corneal papilloma in a Malayan tapir. ( Karpinski, LG; Miller, CL, 2002) |
| "Nine patients (nine eyes) with iridocorneal endothelial (ICE) syndrome underwent trabeculectomy and received postoperative subconjunctival injections of 5-fluorouracil (5-FU) to enhance bleb formation (total 5-FU dose, 30-105 mg; mean, 53." | 7.68 | 5-Fluorouracil after trabeculectomy and the iridocorneal endothelial syndrome. ( Cristol, SM; Grajewski, AL; Parrish, RK; Wright, MM, 1991) |
| "The antimetabolite 5-fluorouracil (5-FU) has been used to inhibit fibroblastic growth to increase the success rate in glaucoma filtration surgery." | 7.67 | Complications of subconjunctival 5-fluorouracil following glaucoma filtering surgery. ( Hersh, P; Kersten, D; Lee, DA; Melamed, S, 1987) |
| "We studied four patients who, having received postoperative 5-fluorouracil after glaucoma filtering operations, developed serious corneal complications." | 7.67 | Serious corneal complications of glaucoma filtering surgery with postoperative 5-fluorouracil. ( Driebe, WT; Heuer, DK; Knapp, A; Stern, GA, 1987) |
| "In this prospective study, 76 patients with primary pterygium (76 eyes) were categorized into two groups: the control group with 31 patients who did not receive cyclosporine treatment, and the cyclosporine group with 45 patients who received topical cyclosporine A (0." | 5.30 | Topical cyclosporine A 0.05% before and after surgery to prevent pterygium recurrence. ( Meneghim, RLFS; Natsuaki, KL; Oliveira, AC; Padovani, CR; Satto, LH; Schellini, SA; Viveiros, MMH, 2019) |
| "In a randomized clinical trial, the authors compared the use of postoperative subconjunctival injections of 5-fluorouracil (5-FU) in 19 eyes with a single intraoperative application of subconjunctival mitomycin (MMC) at the filtering site in 20 eyes at high risk for failure of glaucoma filtering surgery." | 5.07 | Intraoperative mitomycin versus postoperative 5-fluorouracil in high-risk glaucoma filtering surgery. ( Beeson, CC; Bergstrom, TJ; Falck, FY; Higginbotham, EJ; Klein, TB; Lichter, PR; Musch, DC; Skuta, GL, 1992) |
| "A 26-year-old, wild caught, male Malayan tapir at the Miami Metrozoo with bilateral corneal papillomas was serially immobilized and given subconjunctival injections of fluorouracil." | 3.71 | Fluorouracil as a treatment for corneal papilloma in a Malayan tapir. ( Karpinski, LG; Miller, CL, 2002) |
| "To investigate the incidence of complications reportedly caused by the use of 5-fluorouracil (5-FU) in glaucoma filtering surgery, we performed trabeculectomy with 5-FU on 57 eyes of 56 patients with advanced glaucoma." | 3.68 | Incidence of complications following 5-fluorouracil with trabeculectomies. ( Gieser, SC; Jacob, A; Raju, R; Sen, S; Thomas, R, 1993) |
| "Nine patients (nine eyes) with iridocorneal endothelial (ICE) syndrome underwent trabeculectomy and received postoperative subconjunctival injections of 5-fluorouracil (5-FU) to enhance bleb formation (total 5-FU dose, 30-105 mg; mean, 53." | 3.68 | 5-Fluorouracil after trabeculectomy and the iridocorneal endothelial syndrome. ( Cristol, SM; Grajewski, AL; Parrish, RK; Wright, MM, 1991) |
| "The antimetabolite 5-fluorouracil (5-FU) has been used to inhibit fibroblastic growth to increase the success rate in glaucoma filtration surgery." | 3.67 | Complications of subconjunctival 5-fluorouracil following glaucoma filtering surgery. ( Hersh, P; Kersten, D; Lee, DA; Melamed, S, 1987) |
| "We studied four patients who, having received postoperative 5-fluorouracil after glaucoma filtering operations, developed serious corneal complications." | 3.67 | Serious corneal complications of glaucoma filtering surgery with postoperative 5-fluorouracil. ( Driebe, WT; Heuer, DK; Knapp, A; Stern, GA, 1987) |
| "Mitomycin C has been shown in studies to be highly effective but has short-term and long-term side-effects that may be intolerable." | 2.49 | Topical chemotherapy for ocular surface squamous neoplasia. ( Karp, CL; Nanji, AA; Sayyad, FE, 2013) |
| " Based on the Wuerzburg bleb classification score (WBCS) for postoperative wound healing evaluation, 30 of these operations of group A (group B: n = 26) did not receive 5 FU postoperatively (controls), 67 (93) received up to 7 postoperative injections of 5 mg 5 FU (normal dosage group), and 72 (93) received more than 7 injections (high dosage group)." | 1.36 | [Corneal epitheliopathy following trabeculectomy with postoperative adjunctive 5-fluorouracil]. ( Geerling, G; Grehn, F; Klink, T; Reiter, C; Schultheiss, A; Wimmer, S, 2010) |
| "Capecitabine (CPC) was administered as an oral immunosuppressive agent." | 1.34 | Histopathologic evidence of capecitabine corneal toxicity in dogs. ( Bentley, E; Dubielzig, R; McAnulty, J; Milovancev, M; Schmiedt, C; Zarfoss, M, 2007) |
| "To evaluate the efficacy of pulse dosing of topical 5-fluorouracil (5-FU) in the treatment of conjunctival and corneal intraepithelial neoplasia." | 1.31 | 5-Fluorouracil for the treatment of intraepithelial neoplasia of the conjunctiva and cornea. ( Curry, CD; Engelbrecht, NE; Ford, JG; Walter, KA; Yeatts, RP, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (7.69) | 18.7374 |
| 1990's | 16 (30.77) | 18.2507 |
| 2000's | 13 (25.00) | 29.6817 |
| 2010's | 15 (28.85) | 24.3611 |
| 2020's | 4 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| Godin, F | 1 |
| Mercado, C | 3 |
| Larco, P | 1 |
| Pacheco L, MA | 1 |
| Borroni, D | 1 |
| Chacon Aponte, A | 1 |
| Agarwal, A | 1 |
| Kaliki, S | 1 |
| Murthy, SI | 1 |
| Le, VNH | 1 |
| Wabnig, F | 1 |
| Bachmann, B | 1 |
| Cursiefen, C | 1 |
| Aboumourad, RJ | 1 |
| Galor, A | 5 |
| Karp, CL | 7 |
| Chaugule, SS | 1 |
| Park, J | 1 |
| Finger, PT | 1 |
| Polski, A | 1 |
| Sibug Saber, M | 1 |
| Kim, JW | 1 |
| Berry, JL | 1 |
| Venkateswaran, N | 1 |
| Koenig, SB | 1 |
| Koenig, LR | 1 |
| Connor, TB | 1 |
| Simons, KB | 1 |
| Meneghim, RLFS | 1 |
| Satto, LH | 1 |
| Natsuaki, KL | 1 |
| Oliveira, AC | 1 |
| Padovani, CR | 1 |
| Viveiros, MMH | 1 |
| Schellini, SA | 1 |
| Nanji, AA | 1 |
| Sayyad, FE | 1 |
| Wong, RK | 1 |
| Greene, DP | 1 |
| Shield, DR | 1 |
| Eberhart, CG | 1 |
| Huang, JJ | 1 |
| Shayegani, A | 1 |
| Overton, TL | 1 |
| Allbaugh, RA | 1 |
| Whitley, D | 1 |
| Ben-Shlomo, G | 1 |
| Griggs, A | 1 |
| Tofflemire, KL | 1 |
| Whitley, EM | 1 |
| Joag, MG | 1 |
| Sise, A | 1 |
| Murillo, JC | 1 |
| Sayed-Ahmed, IO | 1 |
| Wong, JR | 1 |
| Parrozzani, R | 1 |
| Frizziero, L | 1 |
| Trainiti, S | 1 |
| Testi, I | 1 |
| Miglionico, G | 1 |
| Pilotto, E | 1 |
| Blandamura, S | 1 |
| Fassina, A | 1 |
| Midena, E | 1 |
| Ashkenazy, N | 1 |
| Wang, G | 1 |
| Acosta, CM | 1 |
| Lenhart, PD | 1 |
| Randleman, JB | 1 |
| Grossniklaus, HE | 1 |
| Stulting, RD | 1 |
| Hau, S | 1 |
| Barton, K | 1 |
| Reiter, C | 1 |
| Wimmer, S | 1 |
| Schultheiss, A | 1 |
| Klink, T | 1 |
| Grehn, F | 1 |
| Geerling, G | 1 |
| Shousha, MA | 1 |
| Perez, VL | 1 |
| Hoffmann, R | 1 |
| Ventura, R | 1 |
| Chang, V | 1 |
| Dubovy, SR | 2 |
| Wang, J | 1 |
| Oellers, P | 1 |
| Kao, AA | 1 |
| Abdelaziz, A | 1 |
| Feuer, W | 1 |
| Hirji, N | 1 |
| Griffiths, M | 1 |
| Karpinski, LG | 1 |
| Miller, CL | 1 |
| Schechter, BA | 2 |
| Nagler, RS | 2 |
| Stone, DU | 1 |
| Butt, AL | 1 |
| Chodosh, J | 1 |
| Tomlins, PJ | 1 |
| Savant, V | 1 |
| Quinlan, M | 1 |
| Zarfoss, M | 1 |
| Bentley, E | 1 |
| Milovancev, M | 1 |
| Schmiedt, C | 1 |
| Dubielzig, R | 1 |
| McAnulty, J | 1 |
| Slezak, H | 1 |
| Thomas, R | 1 |
| Jacob, A | 1 |
| Raju, R | 1 |
| Gieser, SC | 1 |
| Sen, S | 1 |
| Hayashi, M | 1 |
| Ibaraki, N | 1 |
| Tsuru, T | 1 |
| Baldassare, RD | 1 |
| Brunette, I | 1 |
| Desjardins, DC | 1 |
| Amyot, M | 1 |
| Yeatts, RP | 2 |
| Ford, JG | 2 |
| Stanton, CA | 1 |
| Reed, JW | 1 |
| Fechtner, RD | 1 |
| Manche, EE | 1 |
| Afshari, MA | 1 |
| Singh, K | 1 |
| Rothman, RF | 1 |
| Liebmann, JM | 1 |
| Ritch, R | 1 |
| Pires, RT | 1 |
| Chokshi, A | 1 |
| Tseng, SC | 1 |
| Waikhom, B | 1 |
| Fraunfelder, FT | 1 |
| Henner, WD | 1 |
| Walkhom, B | 1 |
| Engelbrecht, NE | 1 |
| Curry, CD | 1 |
| Walter, KA | 1 |
| Doe, EA | 1 |
| Budenz, DL | 1 |
| Gedde, SJ | 1 |
| Imami, NR | 1 |
| Lai, MM | 1 |
| Haller, JA | 1 |
| Skuta, GL | 3 |
| Beeson, CC | 1 |
| Higginbotham, EJ | 1 |
| Lichter, PR | 1 |
| Musch, DC | 1 |
| Bergstrom, TJ | 1 |
| Klein, TB | 1 |
| Falck, FY | 1 |
| Phelan, MJ | 2 |
| Franks, WA | 1 |
| Hitchings, RA | 1 |
| Loane, ME | 2 |
| Weinreb, RN | 2 |
| Wright, MM | 1 |
| Grajewski, AL | 1 |
| Cristol, SM | 1 |
| Parrish, RK | 1 |
| Lemp, MA | 1 |
| Peterson, MR | 1 |
| Stanley, SA | 1 |
| Stank, TM | 1 |
| Krupin, T | 1 |
| Feitl, ME | 1 |
| de Keizer, RJ | 1 |
| de Wolff-Rouendaal, D | 1 |
| van Delft, JL | 1 |
| Lee, DA | 1 |
| Hersh, P | 1 |
| Kersten, D | 1 |
| Melamed, S | 1 |
| Knapp, A | 1 |
| Heuer, DK | 1 |
| Stern, GA | 1 |
| Driebe, WT | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Intermediate Term Outcomes of Intraoperative 5-Fluorouracil Versus Mitomycin c in Trabeculectomy Surgery.[NCT00346489] | Phase 4 | 70 participants | Interventional | 2004-09-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for fluorouracil and Corneal Diseases
| Article | Year |
|---|---|
Topical chemotherapy for ocular surface squamous neoplasia.
Topics: Administration, Topical; Antimetabolites, Antineoplastic; Carcinoma in Situ; Conjunctival Neoplasms; | 2013 |
Corneal complications of glaucoma surgery.
Topics: Corneal Diseases; Corneal Transplantation; Fluorouracil; Glaucoma; Glaucoma Drainage Implants; Graft | 2009 |
2 trials available for fluorouracil and Corneal Diseases
| Article | Year |
|---|---|
Topical cyclosporine A 0.05% before and after surgery to prevent pterygium recurrence.
Topics: Adult; Combined Modality Therapy; Conjunctiva; Corneal Diseases; Cyclosporine; Female; Fluorouracil; | 2019 |
Intraoperative mitomycin versus postoperative 5-fluorouracil in high-risk glaucoma filtering surgery.
Topics: Adult; Aged; Aged, 80 and over; Corneal Diseases; Epithelium; Female; Fluorouracil; Glaucoma; Humans | 1992 |
48 other studies available for fluorouracil and Corneal Diseases
| Article | Year |
|---|---|
Epithelial downgrowth leading to graft rejection after penetrating keratoplasty.
Topics: Cornea; Corneal Diseases; Fluorouracil; Graft Rejection; Humans; Infant; Keratoplasty, Penetrating; | 2023 |
Corneal squamous neoplasia: masquerades and management outcomes at a rural eyecare centre.
Topics: Carcinoma, Squamous Cell; Conjunctival Neoplasms; Corneal Diseases; Eye Neoplasms; Fluorouracil; Hum | 2023 |
Epithelial downgrowth after Descemet membrane endothelial keratoplasty.
Topics: Aged; Antimetabolites; Corneal Diseases; Descemet Stripping Endothelial Keratoplasty; Endothelium, C | 2021 |
Case Series: High-resolution Optical Coherence Tomography as an Optical Biopsy in Ocular Surface Squamous Neoplasia.
Topics: Aged; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Biopsy; C | 2021 |
Topical chemotherapy for giant ocular surface squamous neoplasia of the conjunctiva and cornea: Is surgery necessary?
Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Carcinoma, | 2018 |
Extending far and wide: the role of biopsy and staging in the management of ocular surface squamous neoplasia.
Topics: Aged; Antineoplastic Agents; Biopsy; Carcinoma, Squamous Cell; Conjunctival Neoplasms; Corneal Disea | 2019 |
Comparison of Topical 5-Fluorouracil and Interferon Alfa-2b as Primary Treatment Modalities for Ocular Surface Squamous Neoplasia.
Topics: Administration, Ophthalmic; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic | 2019 |
Successful management of epithelial ingrowth after sequential intracameral 5-fluorouracil and Descemet-stripping automated endothelial keratoplasty.
Topics: Aged; Anterior Chamber; Antimetabolites; Combined Modality Therapy; Cornea; Corneal Diseases; Descem | 2019 |
5-Fluorouracil for epithelial downgrowth after Descemet stripping automated endothelial keratoplasty.
Topics: Aged; Antimetabolites; Corneal Diseases; Descemet Stripping Endothelial Keratoplasty; Female; Fluoro | 2013 |
A pulse-dose topical 1% 5-fluorouracil treatment regimen in a young dog with corneal squamous cell carcinoma.
Topics: Administration, Ophthalmic; Animals; Antimetabolites, Antineoplastic; Carcinoma, Squamous Cell; Corn | 2015 |
Topical 5-Fluorouracil 1% as Primary Treatment for Ocular Surface Squamous Neoplasia.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Carcinoma, Squamous Cell; Conjuncti | 2016 |
Topical 1% 5-fluoruracil as a sole treatment of corneoconjunctival ocular surface squamous neoplasia: long-term study.
Topics: Administration, Topical; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Carcinoma, Squamo | 2017 |
Immunosuppression as a Possible Risk Factor for Interferon Nonresponse in Ocular Surface Squamous Neoplasia.
Topics: Administration, Topical; Aged; Antimetabolites, Antineoplastic; Carcinoma, Squamous Cell; Conjunctiv | 2017 |
Confocal microscopic diagnosis of epithelial downgrowth.
Topics: Adolescent; Adult; Aged; Cell Nucleus; Corneal Diseases; Epithelium, Corneal; Eye Injuries, Penetrat | 2008 |
[Corneal epitheliopathy following trabeculectomy with postoperative adjunctive 5-fluorouracil].
Topics: Aged; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Combined Modality Therapy; Corne | 2010 |
Diagnosis and management of conjunctival and corneal intraepithelial neoplasia using ultra high-resolution optical coherence tomography.
Topics: Administration, Topical; Aged; Aged, 80 and over; Biopsy; Carcinoma in Situ; Conjunctival Neoplasms; | 2011 |
Predictors of ocular surface squamous neoplasia recurrence after excisional surgery.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma in Situ; Carcinoma, Squamous Cell; Conjunctival Neoplasms; | 2012 |
Snailtrack corneal changes following subconjunctival injection of 5-fluorouracil.
Topics: Antimetabolites; Conjunctiva; Corneal Diseases; Endothelium, Corneal; Fluorouracil; Glaucoma; Humans | 2012 |
Fluorouracil as a treatment for corneal papilloma in a Malayan tapir.
Topics: Animals; Animals, Zoo; Antimetabolites, Antineoplastic; Conjunctiva; Corneal Diseases; Diagnosis, Di | 2002 |
Successful treatment with 5-Fu.
Topics: Administration, Topical; Aged; Antineoplastic Agents; Carcinoma in Situ; Conjunctival Neoplasms; Cor | 2003 |
Successful treatment with 5-Fu.
Topics: Administration, Topical; Aged; Antineoplastic Agents; Carcinoma in Situ; Conjunctival Neoplasms; Cor | 2003 |
Ocular surface squamous neoplasia: a standard of care survey.
Topics: Administration, Topical; Antineoplastic Agents; Biopsy; Combined Modality Therapy; Conjunctival Neop | 2005 |
Failure of intracameral fluorouracil to resolve an epithelial ingrowth following clear corneal cataract surgery.
Topics: Antimetabolites; Cataract Extraction; Corneal Diseases; Epithelium, Corneal; Fluorouracil; Glaucoma, | 2007 |
Histopathologic evidence of capecitabine corneal toxicity in dogs.
Topics: Animals; Capecitabine; Cornea; Corneal Diseases; Deoxycytidine; Dog Diseases; Dogs; Female; Fluorour | 2007 |
[Drug-induced eye lesions in the aged].
Topics: Aged; Antipsychotic Agents; Aspirin; Cataract; Conjunctival Diseases; Corneal Diseases; Eye Diseases | 1983 |
Incidence of complications following 5-fluorouracil with trabeculectomies.
Topics: Combined Modality Therapy; Corneal Diseases; Fluorouracil; Follow-Up Studies; Glaucoma; Humans; Inci | 1993 |
Lamellar keratoplasty after trabeculectomy with 5-fluorouracil.
Topics: Corneal Diseases; Corneal Transplantation; Female; Fluorouracil; Glaucoma, Open-Angle; Humans; Middl | 1994 |
Corneal ectasia secondary to excessive ocular massage following trabeculectomy with 5-fluorouracil.
Topics: Adult; Antimetabolites; Corneal Diseases; Dilatation, Pathologic; Fluorouracil; Glaucoma; Humans; Ma | 1996 |
Topical 5-fluorouracil in treating epithelial neoplasia of the conjunctiva and cornea.
Topics: Administration, Topical; Adult; Aged; Antimetabolites, Antineoplastic; Biopsy; Carcinoma in Situ; Ch | 1995 |
Management of coexisting pseudophakic bullous keratopathy and open-angle glaucoma.
Topics: Administration, Topical; Aged; Cataract Extraction; Corneal Diseases; Female; Fluorouracil; Follow-U | 1998 |
Delayed corneal epitheliopathy after antimetabolite-augmented trabeculectomy.
Topics: Aged; Antimetabolites; Cornea; Corneal Diseases; Epithelium; Female; Fluorouracil; Humans; Mitomycin | 1998 |
Noninfectious crystalline keratopathy after postoperative subconjunctival 5-fluorouracil.
Topics: Aged; Antimetabolites; Conjunctiva; Cornea; Corneal Diseases; Diagnosis, Differential; Exfoliation S | 1999 |
Amniotic membrane transplantation or conjunctival limbal autograft for limbal stem cell deficiency induced by 5-fluorouracil in glaucoma surgeries.
Topics: Aged; Amnion; Cell Transplantation; Conjunctiva; Corneal Diseases; Epithelial Cells; Epithelium, Cor | 2000 |
Severe ocular irritation and corneal deposits associated with capecitabine use.
Topics: Antineoplastic Agents; Breast Neoplasms; Capecitabine; Corneal Diseases; Deoxycytidine; Female; Fluo | 2000 |
5-Fluorouracil for the treatment of intraepithelial neoplasia of the conjunctiva and cornea.
Topics: Administration, Topical; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Carcinoma in Situ | 2000 |
Long-term surgical outcomes of patients with glaucoma secondary to the iridocorneal endothelial syndrome.
Topics: Adult; Antihypertensive Agents; Corneal Diseases; Endothelium, Corneal; Fluorouracil; Follow-Up Stud | 2001 |
Resolution of epithelial ingrowth in a patient treated with 5-fluorouracil.
Topics: Adult; Anterior Chamber; Antimetabolites; Corneal Diseases; Epithelial Cells; Eye Injuries; Fluorour | 2002 |
Reversible corneal keratinization following trabeculectomy and treatment with 5-fluorouracil.
Topics: Aged; Conjunctiva; Corneal Diseases; Fluorouracil; Glaucoma, Open-Angle; Humans; Intraocular Pressur | 1990 |
Complications of 5--fluorouracil after trabeculectomy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Conjunctiva; Conjunctival Diseases; Corneal Diseases; Fe | 1991 |
Reducing corneal toxicity of 5-fluorouracil in the early postoperative period following glaucoma filtering surgery.
Topics: Aged; Aged, 80 and over; Aphakia; Corneal Diseases; Female; Fluorouracil; Glaucoma, Open-Angle; Huma | 1991 |
5-Fluorouracil after trabeculectomy and the iridocorneal endothelial syndrome.
Topics: Adult; Cataract Extraction; Conjunctiva; Corneal Diseases; Endothelium, Corneal; Fluorouracil; Follo | 1991 |
Striate melanokeratosis.
Topics: Corneal Diseases; Fluorouracil; Humans; Keratosis; Melanosis | 1991 |
Striate melanokeratosis following trabeculectomy with 5-fluorouracil.
Topics: Corneal Diseases; Fluorouracil; Glaucoma, Open-Angle; Humans; Keratosis; Male; Melanosis; Middle Age | 1990 |
Glaucoma secondary to epithelial downgrowth and 5-fluorouracil.
Topics: Anterior Chamber; Cataract Extraction; Cell Division; Corneal Diseases; Epithelium; Eye Enucleation; | 1990 |
Subconjunctival 5-fluorouracil-induced transient striate melanokeratosis.
Topics: Adult; Aged; Corneal Diseases; Fluorouracil; Humans; Keratosis; Melanosis; Middle Aged | 1990 |
Topical application of 5-fluorouracil in premalignant lesions of cornea, conjunctiva and eyelid.
Topics: Aged; Carcinoma in Situ; Conjunctival Diseases; Corneal Diseases; Drug Administration Schedule; Eyel | 1986 |
Complications of subconjunctival 5-fluorouracil following glaucoma filtering surgery.
Topics: Aged; Aged, 80 and over; Conjunctiva; Conjunctival Diseases; Corneal Diseases; Fluorouracil; Glaucom | 1987 |
Serious corneal complications of glaucoma filtering surgery with postoperative 5-fluorouracil.
Topics: Aged; Corneal Diseases; Corneal Ulcer; Female; Fluorouracil; Glaucoma; Humans; Male; Middle Aged; Po | 1987 |